|
Carter Greenbaum
12/20/05
|
Current Price: $15.57
Four-Month
Target Price: $19.80
|
Outlook:
See charts below |
Bluegreen
Corporation's Income has risen at a steady and compounding rate since 2001.
Revenue increased dramatically in 2004 compared to the previous year. This was
due to increased publicity and a new and stronger Public Relations team. This
year we can expect greater revenue growth.
Equity has increased more than two-fold between 2003 and 2004. Debt has
decreased substantially and equity (as mentioned earlier) increased.
*Provided by Bluegreens Corporation
| Market Cap (intraday): |
473.13M |
| Enterprise Value (20-Dec-05)3: |
598.83M |
| Trailing P/E (ttm,
intraday): |
10.55 |
| Forward P/E (fye 31-Dec-06)
1: |
9.16 |
| PEG Ratio (5 yr expected): |
0.67 |
| Price/Sales (ttm): |
0.70 |
| Price/Book (mrq): |
1.51 |
| Enterprise Value/Revenue
(ttm)3: |
0.91 |
| Enterprise Value/EBITDA
(ttm)3: |
5.327 |
|
| Fiscal Year |
| Fiscal Year Ends: |
31-Dec |
| Most Recent Quarter (mrq): |
30-Sep-05 |
|
| Profitability
|
| Profit Margin (ttm): |
6.95% |
| Operating Margin (ttm): |
14.18% |
|
| Management
Effectiveness |
| Return on Assets (ttm): |
8.88% |
| Return on Equity (ttm): |
17.18% |
|
| Income Statement |
| Revenue (ttm): |
659.12M |
| Revenue Per Share (ttm): |
22.253 |
| Qtrly Revenue Growth (yoy): |
5.00% |
| Gross Profit (ttm): |
350.17M |
| EBITDA (ttm): |
112.42M |
| Net Income Avl to Common (ttm): |
45.79M |
| Diluted EPS (ttm): |
1.48 |
| Qtrly Earnings Growth (yoy): |
14.40% |
|
| Balance Sheet |
| Total Cash (mrq): |
67.95M |
| Total Cash Per Share (mrq): |
2.236 |
| Total Debt (mrq): |
203.07M |
| Total Debt/Equity (mrq): |
0.662 |
| Current Ratio (mrq): |
7.657 |
| Book Value Per Share (mrq): |
10.098 |
|
| Cash Flow Statement |
| Operating Cash Flow (ttm): |
79.50M |
| Levered Free Cash Flow (ttm): |
-72.15M |
|
|
|
|
Highlights:
 The enterprise Value is significantly
higher than the Market Cap. This shows the stock is undervalued.
The P/E is low compared to the industry,
meaning that the Price is low and earnings high.
The P/S and EV/R are both below 1. Net
income generated from sales increased dramatically this past year. The result is
a price which can not keep up with the rising sales. Though, P/S for this
insurance sector is generally low, AEG's P/S shows the company is grossly
undervalued.
The Revenue per Share is almost double
the current share price.
Quarterly earnings and revenue growth are
up.
Low debt/Equity
There are very few investors shorting
this stock.
In analyzing when to buy this stock, I refer to several technical analysis
highlights:
Bollinger Bands
indicate AEG is oversold at the current time.
Money Flow Index and Williams %R indicate,
also, that BXG is oversold and the price should rise soon.
| 
